Aikaterini Liapi Chirine Atat Vincent Dunet Apostolos Sarivalasis
10.1177/2050313X231176401
SAGE Open Med Case Rep
2023 May 23;11:2050313X231176401.
posterior reversible encephalopathy syndrome (pres) bevacizumab olaparib ovarian cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/37250819/
Case Reports
PMC10214094
37250819
Dual first-line maintenance by PARP inhibitor and bevacizumab can cause confusion in high-grade serous ovarian cancer: A case of PRES and a review of the literature
2023